NY-ESO-1 expression in solid tumors predicts prognosis
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference39 articles.
1. Immune targets and neoantigens for cancer immunotherapy and precision medicine;Wang;Cell Res,2016
2. New York esophageal squamous cell carcinoma-1 and cancer immunotherapy;Esfandiary;Immunotherapy,2015
3. Cancer-testis antigens and immunotherapy in the light of cancer complexity;Grizzi;Int Rev Immunol,2015
4. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans;Davis;Proc Natl Acad Sci USA,2004
5. Regulatory T-cell mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma;Nicholaou;Clin Cancer Res,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma;ESMO Open;2024-08
2. Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer;Annals of Gastroenterological Surgery;2023-11-20
3. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review);International Journal of Oncology;2023-05-05
4. Expression and Prognostic Significance of PD-L1 and NY-ESO1 in Gallbladder Carcinoma;In Vivo;2023
5. The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients With Gastrointestinal Stromal Tumor;Anticancer Research;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3